Lipid Regulators Market

Lipid Regulators Market

Lipid Regulators Market Forecasts to 2028 - Global Analysis By Product (Monoglycerols, Cholesterol, Sphingomyelin, Diacylglycerols, Glycerophospholipid), Type (Non-Statins, Statins), Phase (Pre-Clinical, Clinical), Application and Geography

4.6 (19 reviews)
4.6 (19 reviews)
Published: 2022 ID: SMRC21976

This report covers the impact of COVID-19 on this global market

Years Covered


Estimated Year Value (2022)

US $7.38 BN

Projected Year Value (2028)

US $13.58 BN

CAGR (2022 - 2028)


Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Fastest Growing Market

North America

According to Stratistics MRC, the Global Lipid Regulators Market is accounted for $7.38 billion in 2022 and is expected to reach $13.58 billion by 2028 growing at a CAGR of 10.7% during the forecast period. Lipids are essential bio molecules for the metabolism to operate as it should. However, an excessive amount of any lipid is thought to be hazardous. In addition to regulating cholesterol, lipids also deal with osteoporosis, which is characterised by weak bones that are easily broken, and they prevent myocardial infarctions, often known as heart attacks. There has been a rise in demand for lipid regulators recently as a result of the frequency of disorders like dyslipidemia. Lipids are typically insoluble in water; however they are readily soluble in alcohols and organic solvents. Lipids are made up of esters and fats with similar properties. Energy storage is one of the fundamental qualities of lipid nutrition, which the human body needs for healthy operation.

According to the 2022 American Heart Association (AHA) report, approximately 244.1 million people were living with ischemic heart disease (IHD) around the world had the highest prevalence rates of IHD in the world in 2020. According to the World Aging Report 2022, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. By 2050, the number of people aged 65 years or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. According to the Centers for Disease Control and Prevention (CDC) data updated in May 2022, from March 2017 to March 2020, 41.9% of Americans were obese.

Market Dynamics:


High Prevalence of Lifestyle-related Diseases

Lipids are organic compounds in the form of fats, oils, and hormones that are insoluble in water, and are being extensively used in the pharmaceutical, food, and cosmetics & personal care industries. However, growth in chronic and lifestyle-related diseases is triggering the demand for lipid-based drug delivery systems. Companies in the lipids market are establishing stable revenue streams by expanding output capacities for pharmaceutical lipids. Manufacturers are diversifying the production of functional lipids such as omega-3, phytosterols, and conjugated linoleic acids that help in the management of bone health, blood pressure, and cardiovascular health.


Lack of awareness

The factor that is obstructing the expansion of the lipid regulators market is due to lack of awareness among the people about lipid regulators. In emerging nations, a lack of awareness about innovative treatment methods will impede market expansion. The market will be challenged by a scarcity of qualified workers and a lack of healthcare facilities in developing nations.


Rise in chronic diseases

The adoption of non-invasive procedures, rising funding levels for the development of cutting-edge and technologically innovative testing products, the prevalence of geriatric and obese populations around the world, rising cardiovascular disease and diabetes cases, and rising geriatric and obese populations are all expected to contribute to the market's growth.


Higher risk of medical conditions

For good health, lipids are necessary. However, consuming an excessive amount of them can increase your risk of developing diseases including liver disease and heart disease. Increasing "bad" LDL cholesterol in the blood can increase the risk of heart disease and stroke. This risk can be increased by consuming too much saturated fats in the diet.

Covid-19 Impact

In order to assure a steady supply of lipid products throughout the corona virus crisis, manufacturers in the lipids industry are maintaining optimal inventory levels. To lessen reliance on imports of raw materials, they are expanding their local production capacity. Prior to expanding into new areas, businesses engage in mergers and acquisitions (M&As) to broaden their market reach.

The Branded statins segment is expected to be the largest during the forecast period

The Branded statins segment is estimated to have a lucrative growth, due more successful than other lipid-regulating medications at reducing LDL-cholesterol levels. Atorvastatin, Fluvastatin, Pravastatin, Rosuvastatin, and Simvastatin are a few of the statins that are on the market. Consequently, it is anticipated that as the incidence of dyslipidemia rises, so will the demand for these statins.

The Personal Care & Cosmetics segment is expected to have the highest CAGR during the forecast period

The Personal Care & Cosmetics segment is anticipated to witness the fastest CAGR growth during the forecast period, due to urbanization growth has significantly altered lifestyles across the globe. The personal care and cosmetics business has benefited as a result. Social media and digitization have been extremely important for cosmetics sales. It is anticipated that rising customer preference for cosmetics made with herbal ingredients would contribute to the expansion of the lipids industry. Thus, it is projected that an increase in cosmetics sales will stimulate the lipids industry.

Region with highest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increased demand for nutraceutical products, expansion in the pharmaceutical industry, rising per capita disposable income in the nation, and significant demand for lipids in the personal care & cosmetics, food & beverage, and nutraceutical industries, the country has seen an increase in lipid demand.

Region with highest CAGR:

North American is projected to have the highest CAGR over the forecast period, owing to the highest prevalence of Obesity and Diabetes in the world. The type 2 diabetes, the most common form of the disease, is more likely to develop in those who are overweight or obese. Dyslipidemia is predicted to become more common as diabetes prevalence raises the risk of dyslipidemia. The health care systems in rising nations are advanced and well-organized, nonetheless. Additionally, these systems support innovation and research. These nations benefit from the presence of several international market players as a result.

Key players in the market

Some of the key players profiled in the Lipid Regulators Market include Abbott Laboratories, Novartis Merck Millipore Limited, Sun Pharmaceutical Industries Limited, Astellas Pharma, Moderna Inc., Bentley Pharmaceuticals, Archer Daniels Midland Company, AstraZeneca, Andrx Corporation, Bristol-Myers Squibb, NOF Corporation, Stepan Company, Abitec Corporation, Amgen, Teva Pharmaceuticals, Matreya Llc, Lipoid GmbH., Avanti Polar Lipids Inc. and Tokyo Chemical Industry Co., Ltd.

Key Developments:

In May 2022, Sun Pharmaceutical Industries Limited launched a first-in-class oral drug, Bempedoic Acid, in India for reducing low-density lipoprotein (LDL) cholesterol. The company launched the drug under the brand name Brillo.

In December 2021, Novartis announced that its Leqvio (inclisiran), the first and only small interfering RNA (siRNA) therapy to lower low-density lipoprotein cholesterol (also known as bad cholesterol or LDL-C), with two doses a year, following an initial dose and one every three months, has been approved by the US Food and Drug Administration (FDA).

In May 2020, Moderna Inc., a U.S.-based pharmaceutical company, extended a deal with Corden Pharma to secure large volume of lipids used to produce its experimental COVID-19 vaccine in order to meet the increasing demand for the vaccine

Products Covered:
• Monoglycerols
• Cholesterol
• Sphingomyelin
• Diacylglycerols
• Glycerophospholipid
• Fatty Acids
• Triglycerides
• Phospholipids
• Sphingolipids
• Ionizable Lipids
• Other Products

Types Covered:
• Non-Statins
• Statins
• Other Types

Phases Covered:
• Pre-Clinical
• Clinical

Applications Covered:
• Pharmaceuticals
• Retail
• Online
• Personal Care & Cosmetics
• Food & Beverages
• Nutrition & Supplements
• Other Applications

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Lipid Regulators Market, By Product
5.1 Introduction
5.2 Monoglycerols
5.3 Cholesterol
5.4 Sphingomyelin
5.5 Diacylglycerols
5.6 Glycerophospholipid
5.7 Fatty Acids
5.8 Triglycerides
5.9 Phospholipids
5.10 Sphingolipids
5.11 Ionizable Lipids
5.11.1 siRNA
5.11.2 mRNA
5.12 Other Products

6 Global Lipid Regulators Market, By Type
6.1 Introduction
6.2 Non-Statins
6.2.1 Nicotinic Acid Derivatives
6.2.2 Fibric-Acid Derivatives
6.2.3 Bile-Acid Sequestrants
6.3 Statins
6.3.1 Statin Combinations
6.3.2 Branded Statins
6.3.3 Generic Statins
6.4 Other Types

7 Global Lipid Regulators Market, By Phase
7.1 Introduction
7.2 Pre-Clinical
7.3 Clinical

8 Global Lipid Regulators Market, By Application
8.1 Introduction
8.2 Pharmaceuticals
8.2.1 Scientific Research
8.2.2 Vaccines & Drugs
8.3 Retail
8.4 Online
8.5 Personal Care & Cosmetics
8.6 Food & Beverages
8.7 Nutrition & Supplements
8.8 Other Applications

9 Global Lipid Regulators Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Abbott Laboratories
11.2 Novartis
11.3 Merck Millipore Limited
11.4 Sun Pharmaceutical Industries Limited
11.5 Astellas Pharma
11.6 Moderna Inc.
11.7 Bentley Pharmaceuticals
11.8 Archer Daniels Midland Company
11.9 AstraZeneca
11.10 Andrx Corporation
11.11 Bristol-Myers Squibb
11.12 NOF Corporation
11.13 Stepan Company
11.14 Abitec Corporation
11.15 Amgen
11.16 Teva Pharmaceuticals
11.17 Matreya Llc
11.18 Lipoid GmbH.
11.19 Avanti Polar Lipids Inc.
11.20 Tokyo Chemical Industry Co., Ltd.

List of Tables
1 Global Lipid Regulators Market Outlook, By Region (2020-2028) ($MN)
2 Global Lipid Regulators Market Outlook, By Product (2020-2028) ($MN)
3 Global Lipid Regulators Market Outlook, By Monoglycerols (2020-2028) ($MN)
4 Global Lipid Regulators Market Outlook, By Cholesterol (2020-2028) ($MN)
5 Global Lipid Regulators Market Outlook, By Sphingomyelin (2020-2028) ($MN)
6 Global Lipid Regulators Market Outlook, By Diacylglycerols (2020-2028) ($MN)
7 Global Lipid Regulators Market Outlook, By Glycerophospholipid (2020-2028) ($MN)
8 Global Lipid Regulators Market Outlook, By Fatty Acids (2020-2028) ($MN)
9 Global Lipid Regulators Market Outlook, By Triglycerides (2020-2028) ($MN)
10 Global Lipid Regulators Market Outlook, By Phospholipids (2020-2028) ($MN)
11 Global Lipid Regulators Market Outlook, By Sphingolipids (2020-2028) ($MN)
12 Global Lipid Regulators Market Outlook, By Ionizable Lipids (2020-2028) ($MN)
13 Global Lipid Regulators Market Outlook, By siRNA (2020-2028) ($MN)
14 Global Lipid Regulators Market Outlook, By mRNA (2020-2028) ($MN)
15 Global Lipid Regulators Market Outlook, By Other Products (2020-2028) ($MN)
16 Global Lipid Regulators Market Outlook, By Type (2020-2028) ($MN)
17 Global Lipid Regulators Market Outlook, By Non-Statins (2020-2028) ($MN)
18 Global Lipid Regulators Market Outlook, By Nicotinic Acid Derivatives (2020-2028) ($MN)
19 Global Lipid Regulators Market Outlook, By Fibric-Acid Derivatives (2020-2028) ($MN)
20 Global Lipid Regulators Market Outlook, By Bile-Acid Sequestrants (2020-2028) ($MN)
21 Global Lipid Regulators Market Outlook, By Statins (2020-2028) ($MN)
22 Global Lipid Regulators Market Outlook, By Statin Combinations (2020-2028) ($MN)
23 Global Lipid Regulators Market Outlook, By Branded Statins (2020-2028) ($MN)
24 Global Lipid Regulators Market Outlook, By Generic Statins (2020-2028) ($MN)
25 Global Lipid Regulators Market Outlook, By Other Types (2020-2028) ($MN)
26 Global Lipid Regulators Market Outlook, By Phase (2020-2028) ($MN)
27 Global Lipid Regulators Market Outlook, By Pre-Clinical (2020-2028) ($MN)
28 Global Lipid Regulators Market Outlook, By Clinical (2020-2028) ($MN)
29 Global Lipid Regulators Market Outlook, By Other Phases (2020-2028) ($MN)
30 Global Lipid Regulators Market Outlook, By Application (2020-2028) ($MN)
31 Global Lipid Regulators Market Outlook, By Pharmaceuticals (2020-2028) ($MN)
32 Global Lipid Regulators Market Outlook, By Scientific Research (2020-2028) ($MN)
33 Global Lipid Regulators Market Outlook, By Vaccines & Drugs (2020-2028) ($MN)
34 Global Lipid Regulators Market Outlook, By Retail (2020-2028) ($MN)
35 Global Lipid Regulators Market Outlook, By Online (2020-2028) ($MN)
36 Global Lipid Regulators Market Outlook, By Personal Care & Cosmetics (2020-2028) ($MN)
37 Global Lipid Regulators Market Outlook, By Food & Beverages (2020-2028) ($MN)
38 Global Lipid Regulators Market Outlook, By Nutrition & Supplements (2020-2028) ($MN)
39 Global Lipid Regulators Market Outlook, By Other Applications (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.